Discover groundbreaking innovations from Switzerland's early-stage life science start-ups at Nucleate Switzerland's pitching session. These start-ups, part of Nucleate's Activator program, are revolutionizing human health challenges. Run by academic trainees, Nucleate fosters technology commercialization, offering equity-free support and connecting budding entrepreneurs with a prestigious advisor network.
May 5, 16:45-17:30, room Singapore
Name | Position | Institution |
---|---|---|
Börte Emiroglu | Leadership member | Nucleate |
Ebru Topcu | Leadership member | Nucleate |
Tianlan Cai | Leadership member | Nucleate |
Company name | Pitcher | Title of presentation | Link to company website |
---|---|---|---|
Parabolis | Josh Mesfin | Parabolis: Pioneering Microsized, Smart Healthcare | |
NeXendia | Bogdan Mateescu | NeXendia: Decoding Free RNA to Advance Therapies | |
UNOMR | Til Schlotter | Revolutionizing Proteomics with Nanopores | |
CALDRE. | Felix Alexander Baier | Liver specific therapies that combat cholestatic liver injury, sparing patients from transplantation | |
InSEIT | David Roura Padrosa | Immobilize to go further - AI driven design of reusable biocatalysts |
Name | Position | Institution |
---|---|---|
Katharina Kreymborg | SVP,CSO, Partner | Curie.Bio |
Daniel Bode | Analyst | Forbion |